Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses

Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses

This clinical study describes the intralesional application of the plasmid DNA encoding two therapeutic species-specific growth factors: vascular endothelial growth factor (VEGF164) and fibroblast growth factor 2 (FGF2) in seven horses to restore naturally occurring injuries of the superficial digit...

Full description

Bibliographic Details
Main Authors: Milomir Kovac, Yaroslav A. Litvin, Ruslan O. Aliev, Elena Y. Zakirova, Catrin S. Rutland, Andrey P. Kiyasov, Albert A. Rizvanov
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Pharmacology
Subjects:
gene therapy
horse
tendon injuries
superficial digital flexor tendon
suspensory ligament
vascular endothelial growth factor 164
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00978/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.00978/full

Similar Items